GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Inventories, Raw Materials & Components
中文

Sanofi (Sanofi) Inventories, Raw Materials & Components : $0 Mil (As of Jun. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Sanofi Inventories, Raw Materials & Components?

Sanofi's inventories, raw materials & components for the quarter that ended in Jun. 2023 was $0 Mil.

Sanofi's quarterly raw materials increased from Jun. 2022 ($0 Mil) to Dec. 2022 ($1,561 Mil) but then declined from Dec. 2022 ($1,561 Mil) to Jun. 2023 ($0 Mil).

Sanofi's annual raw materials increased from Dec. 2021 ($1,444 Mil) to Dec. 2022 ($1,561 Mil) and increased from Dec. 2022 ($1,561 Mil) to Dec. 2023 ($1,690 Mil).

Sanofi Inventories, Raw Materials & Components Historical Data

The historical data trend for Sanofi's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Inventories, Raw Materials & Components Chart

Sanofi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,207.78 1,554.75 1,444.07 1,561.44 1,690.29

Sanofi Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,444.07 - 1,561.44 - 1,690.29

Sanofi Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Sanofi (Sanofi) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
XPAR:VIRP LLY JNJ MRK ABBV LSE:AZN XSWX:ROG XSWX:NOVN PFE AMGN BMY GILD LSE:GSK TSE:4519 TSE:4568 SHSE:600276 BIIB XTER:BAYN TSE:4578 SHSE:600436
Traded in Other Exchanges
SNYNF:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria
Address
46, avenue de la Grande Armée, Paris, FRA, 75017
Website
https://www.sanofi.com
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.